Loading...
XTAI4164
Market cap210mUSD
Dec 27, Last price  
41.40TWD
1D
-0.84%
1Q
-4.06%
Jan 2017
-5.48%
IPO
-70.99%
Name

CHC Healthcare Group

Chart & Performance

D1W1MN
XTAI:4164 chart
P/E
16.49
P/S
1.78
EPS
2.51
Div Yield, %
4.70%
Shrs. gr., 5y
2.12%
Rev. gr., 5y
9.11%
Revenues
3.88b
+30.35%
170,398,0001,867,510,0001,995,368,0001,989,670,0002,062,991,0002,091,026,0002,395,331,0002,205,206,0002,117,116,0002,507,466,0002,950,052,0002,554,911,0002,439,564,0002,974,352,0003,877,137,000
Net income
419m
+17.47%
6,299,000483,548,000583,450,000430,685,000296,862,000265,766,000226,518,000158,932,000-86,695,000323,422,000395,172,000366,389,000381,633,000356,571,000418,866,000
CFO
963m
+46.59%
-61,917,000510,142,000477,215,000295,942,000869,311,000634,233,000504,900,0001,137,168,000293,816,000390,688,0001,189,693,000915,465,000692,795,000656,659,000962,588,000
Dividend
Jul 10, 20242.00487 TWD/sh
Earnings
Mar 11, 2025

Profile

CHC Healthcare Group, together with its subsidiaries, provides a range of healthcare management services in Taiwan and internationally. It sells, installs, maintains, leases, and distributes medical equipment. The company is also involved in the provision of business management consultation and education training; elderly care business; and radiation sterilization business. In addition, it offers a range of equipment in the areas of radiation oncology, neurology, medical imaging, ophthalmology, and surgery. The company was founded in 1977 and is headquartered in Taipei, Taiwan.
URL
http://www.chcg.com/
IPO date
Oct 18, 2011
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
3,877,137
30.35%
2,974,352
21.92%
2,439,564
-4.51%
Cost of revenue
3,263,384
2,494,435
1,945,920
Unusual Expense (Income)
NOPBT
613,753
479,917
493,644
NOPBT Margin
15.83%
16.14%
20.23%
Operating Taxes
134,192
95,185
110,787
Tax Rate
21.86%
19.83%
22.44%
NOPAT
479,561
384,732
382,857
Net income
418,866
17.47%
356,571
-6.57%
381,633
4.16%
Dividends
(324,722)
(323,879)
(313,648)
Dividend yield
2.75%
3.88%
4.44%
Proceeds from repurchase of equity
18,368
14,361
4,189,510
BB yield
-0.16%
-0.17%
-59.30%
Debt
Debt current
616,469
454,639
980,931
Long-term debt
4,832,811
4,766,398
4,122,403
Deferred revenue
657,915
645,381
638,653
Other long-term liabilities
63,180
55,270
38,940
Net debt
3,309,600
3,445,706
3,301,179
Cash flow
Cash from operating activities
962,588
656,659
692,795
CAPEX
(582,944)
(682,633)
(514,091)
Cash from investing activities
(500,465)
(339,979)
(990,353)
Cash from financing activities
(42,048)
(346,452)
415,058
FCF
300,732
(211,108)
(165,833)
Balance
Cash
2,026,850
1,719,904
1,919,231
Long term investments
112,830
55,427
(117,076)
Excess cash
1,945,823
1,626,613
1,680,177
Stockholders' equity
2,629,566
2,926,369
2,851,469
Invested Capital
10,758,836
10,433,222
10,194,190
ROIC
4.53%
3.73%
3.98%
ROCE
4.79%
3.95%
4.12%
EV
Common stock shares outstanding
193,571
191,812
185,673
Price
61.10
40.30%
43.55
14.45%
38.05
-3.79%
Market cap
11,827,188
41.59%
8,353,413
18.24%
7,064,858
-11.31%
EV
15,453,879
12,060,599
10,595,373
EBITDA
1,208,216
979,299
954,236
EV/EBITDA
12.79
12.32
11.10
Interest
89,001
71,267
62,516
Interest/NOPBT
14.50%
14.85%
12.66%